Depersonalization-derealization syndrome
induced by reboxetine
by
Khazall Y, Zullino D.
Swiss Med Wkly. 2003 Jul 12;133(27-28):398-399

ABSTRACT

A high variety of factors have been implicated in the emergence of depersonalisation and derealisation episodes, including different drugs. A case abruptly induced by two applications of reboxetine, a selective and specific norepinephrine reuptake inhibitor, is reported occurring in a 50-yearold woman treated for a major depressive episode. The episode rapidly remitted after discontinuation of reboxetine. Previous data having indicated a role of the serotonin system in the pathophysiology of the phenomenon, a noradrenaline induced serotonin liberation of Raphe neurons is suggested as possible underlying mechanism.

Stress
Selectivity
Noradrenaline
NARIs and SSRIs
Reboxetine and the rat
Reboxetine: product info
Reboxetine and the elderly
Reboxetine and noradrenaline
Noradrenaline, anxiety and mood disorders

Refs
HOME
HedWeb
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best to Take Crack Cocaine?